# CYPRESS - CYPHER for Evaluating Sustained Safety

> **NCT00954707** · PHASE4 · UNKNOWN · sponsor: **Cordis US Corp.** · enrollment: 2509 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Clopidogrel & Aspirin, Prasugrel & Aspirin
- **DRUG:** Placebo & Aspirin

## Key facts

- **NCT ID:** NCT00954707
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2012-01
- **Final completion:** 2016-03
- **Target enrollment:** 2509 (ACTUAL)
- **Last updated:** 2014-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954707, "CYPRESS - CYPHER for Evaluating Sustained Safety". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00954707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*